Generate:Biomedicines vs Pathos AI
Which Drug Discovery AI tool is better in 2026?
Generate:Biomedicines
Generative AI for programmable protein therapeutics
Pathos AI
Patient-centric, AI-powered drug development company focused on accelerating cancer therapies
Side-by-side
Generate:Biomedicines is the more established option (raised $700M); pricing is comparable on both sides.
| Metric | Generate:Biomedicines | Pathos AI |
|---|---|---|
| Taglinei | Generative AI for programmable protein therapeutics | Patient-centric, AI-powered drug development company focused on accelerating cancer therapies |
| Foundedi | 2018🏆 | 2022 |
| HQi | Somerville, United States | — |
| Employeesi | — | 11-50🏆 |
| Neuron scorei | 77🏆 | 57 |
| Total fundingi | $700M🏆 | $467M |
| Latest roundi | Series C · Sep 2023 | Series D · May 2025 |
| Valuationi | — | $1.6B🏆 |
| Cheapest paid plani | Pricing not disclosed | Pricing not disclosed |
| Free plani | ✗ | ✓ |
| Free triali | ✗ | ✓ |
| Top tier pricei | Pricing not disclosed | Pricing not disclosed |
| Pricing summaryi | Custom | Free |
| Categoriesi |
Capability matrix
Developer-facing capabilities and access signals for Generate:Biomedicines and Pathos AI.
| Capability | Generate:Biomedicines | Pathos AI |
|---|---|---|
| MCP support | ✗ | ✗ |
| Public API | ✗ | ✗ |
| Webhooks | ✗ | ✗ |
| OAuth 2.0 | ✗ | ✗ |
| SDK languages | — | — |
| Free plan | ✗ | ✓ |
| Free trial | ✗ | ✓ |
| Verified | ✗ | ✗ |
| Active deal | ✗ | ✗ |
🟢 Strengths of Generate:Biomedicines
- Has raised more capital ($700M vs $467M)
- Higher Neuron score (77 vs 57)
- More mature (2018)
🔵 Strengths of Pathos AI
- Offers a free plan
- Offers a free trial
- Newer company (2022)
Which should you choose?
Choose Pathos AI if price matters most — it starts at Free, which is friendlier for teams watching burn. Both Drug Discovery tools ship core features, so the cost delta often decides it for small teams and solo operators.
Choose Generate:Biomedicines if you want the most established option — it has raised $700M, suggesting more runway for enterprise features, support, and long-term roadmap. For mission-critical workflows or larger teams, that stability often outweighs a lower monthly price.
Frequently asked questions
Generate:Biomedicines vs Pathos AI — which is better?
It depends on your priority. Generate:Biomedicines has raised more capital and is the more established option; Pathos AI has broader feature depth. See the side-by-side table above.
Is Generate:Biomedicines cheaper than Pathos AI?
No — Pathos AI's cheapest paid plan is Free, while Generate:Biomedicines's is Custom.
Do Generate:Biomedicines and Pathos AI offer free plans?
Generate:Biomedicines: Paid only. Pathos AI: Yes, has a free plan.
Explore more Drug Discovery tools
Contextual paths to related AI startups, deals and rankings.